Published by Coherent Market Insights
Posted on October 4, 2021
5 min readLast updated: January 31, 2026
The PICC market is set to reach $1,369.9 Mn by 2028, driven by healthcare spending and chronic disease prevalence, with North America leading growth.
Peripherally inserted, or PICC as it is also known, catheters are usually used for long-lasting, one-time access to a specific body part. The catheter can be a very valuable tool in medical care especially for those patients who have had their circulatory systems compromised by surgery or an accident. The use of a catheter introduced via a vein makes this procedure much more comfortable for the patient because the catheter is placed in an area that is out of the way and hidden from view. Patients who undergo short-term access to a specific body part via the use of a PICC are far less likely to develop complications than those who use typical long-acting peripheral venous access devices. These devices can cause several complications if not used properly because they are made of thin, hollow needles. This creates an entry point for bacteria that can lead to infection and also cause nausea and diarrhea.
Request For Sample Copy of This Premium Research Peripherally Inserted Central Catheters Market @
https://www.coherentmarketinsights.com/insight/request-sample/4048
Increasing expenditure on the healthcare industry coupled with the rise in the prevalence of chronic disease is projected to drive market growth. The growing geriatric population is increasing prevalence of the various chronic disease is again fueling the market growth of the peripherally inserted central catheters. According to the World Health Organization, by 2050, the world’s population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. Also, increasing advancement in the catheters device is again anticipated to foster the market growth of the peripherally inserted central catheters over the forecast period.
North America is expected to gain significant growth over the forecast period and this is attributed to increasing healthcare expenditure by the regional government coupled with the continuous launch of the new and advanced product. For instance, in March 2020, Access Vascular Inc. received FDA clearance for the second generation of its HydroPICC peripherally inserted central catheter (PICC), which has demonstrated a thrombus accumulation rate 30 times less than traditional PICCs1 and which may provide the potential to reduce catheter occlusions.
Key Developments:
In July 2018, 3M Korea announced that it has launched a new centralized catheter anchoring system that reduces the risk of bloodstream infection, called the “PICC/CVC securement device+CHG Dressing” package system.
In December 2017, B. Braun Medical Inc. recently introduced the Introcan Safety® Deep Access IV Catheters to its growing portfolio of products that help improve the success of peripheral intravenous PIV access.
Major Players in Peripherally Inserted Central Catheters Market
AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated., Argon Medical Devices, Inc., Cook Medical Inc., ICU Medical, Inc., Medical Components, Inc., Access Vascular, and Vygon (UK) Ltd.
Ask for PDF sample copy of the Peripherally Inserted Central Catheters market report @
https://www.coherentmarketinsights.com/insight/request-pdf/4048
Peripherally Inserted Central Catheters Market insights will improve the revenue impact of businesses in various industries:
• providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Peripherally Inserted Central Catheters Market
• Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Peripherally Inserted Central Catheters market and offers solutions
• assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
• provides an understanding of disruptive technology trends to help businesses make their transitions smoothly
• helping leading companies make strategy recalibrations ahead of their competitors and peers
• Offers insights into promising growth for top players aiming to retain their leadership position in the market & supply-side analysis of the Peripherally Inserted Central Catheters market.
Reasons to Purchase this Report
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4048
In conclusion, the Peripherally Inserted Central Catheters market report presents the descriptive analysis of the parent market supported elite players, present, past, and artistic movement information which is in a position to function as a profitable guide for all the Peripherally Inserted Central Catheters industry business competitors. Our expert research analyst’s team has been trained to supply in-depth marketing research reports from every individual sector which can be helpful to know the industry data within the most precise way.
Contact:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Peripherally Inserted Central Catheters Market to be valued at US$ 1,369.9 Mn by 2028, Expected to exhibit At a CAGR of 6.9% during the forecast period 2021-2028 appeared first on Gatorledger.
The article discusses the growth of the Peripherally Inserted Central Catheters market, projected to reach $1,369.9 Mn by 2028.
Increased healthcare expenditure and the rising prevalence of chronic diseases are key drivers of market growth.
North America is expected to lead due to significant healthcare investments and technological advancements.
Explore more articles in the Research Reports category
